The histone deacetylase inhibitor sodium butyrate in combination with brain-derived neurotrophic factor reduces the viability of DAOY human medulloblastoma cells.

Nör, Carolina; de Farias, Caroline Brunetto; Abujamra, Ana Lucia; Schwartsmann, Gilberto; Brunetto, Algemir Lunardi; Roesler, Rafael

Nör, Carolina; de Farias, Caroline Brunetto; Abujamra, Ana Lucia; Schwartsmann, Gilberto; Brunetto, Algemir Lunardi; Roesler, Rafael.

Affiliation

Nör C; Cancer Research Laboratory, University Hospital Research Center (CPE-HCPA), Porto Alegre, RS, Brazil.

Childs Nerv Syst ; 27(6): 897-901, 2011 Jun.

Article in En | MEDLINE | ID: mdl-21560052

Subject(s)

Brain-Derived Neurotrophic Factor/administration & dosage; Butyrates/administration & dosage; Cerebellar Neoplasms/pathology; Histone Deacetylase Inhibitors/administration & dosage; Medulloblastoma/pathology; Butyrates/chemistry; Cell Line, Tumor; Cell Survival/drug effects; Cerebellar Neoplasms/drug therapy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Histone Deacetylase Inhibitors/chemistry; Humans; Medulloblastoma/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Butyrates / Cerebellar Neoplasms / Brain-Derived Neurotrophic Factor / Histone Deacetylase Inhibitors / Medulloblastoma Limits: Humans Language: En Journal: Childs Nerv Syst Journal subject: NEUROLOGIA / PEDIATRIA Year: 2011 Type: Article Affiliation country: Brazil

Fulltext

XML

PubMed Links

Search on Google